Ceribell, Inc. CBLL

About Ceribell, Inc. (CBLL): stock profile, AI score and financials

Ceribell, Inc. (CBLL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CBLL at 29.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,501 of 2,925 stocks — the bottom half of the AI-ranked universe. CBLL scores in the top quartile across revenue growth (90.8). Areas of concern include balance sheet strength (6.2) and free cash flow (9.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 12.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Ceribell, Inc. reports quarterly revenue of $28.1M, net income of $-19.3M, an operating margin of -71.1%. CBLL trades on the Nasdaq exchange and files with the SEC under CIK 1861107. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CBLL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ceribell, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1861107 →